Healthcare Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Releases.

Press releases published on September 25, 2026

2 hours ago

National Association of Specialty Pharmacy Honors Poster Award Winners and Scholarship Recipients at inSPire2026

Indeterminate GlobeNewswire

2 hours ago

Tilray Brands to Announce First Quarter Fiscal Year 2027 Financial Results on October 8, 2026

Indeterminate GlobeNewswire

14 hours ago

Latest Virtual Rehabilitation Telerehabilitation Systems Market Research,Highlights Future Industry Trends And Forecasts

Indeterminate EIN Presswire

14 hours ago

Vitamin C Gummies Market Trends And Forecast Analysis Reveal Strong Long-Term Potential

Indeterminate EIN Presswire

14 hours ago

Vitamin C Zinc Lozenges Market To Reach $3.49 Billion By 2030 Driven By Expanding Industry Demand

Indeterminate EIN Presswire

2 hours ago

Teladoc Health Announces Chief Legal Officer Transition

Indeterminate GlobeNewswire

2 hours ago

CDT Equity Inc. Announces Reverse Stock Split

Indeterminate GlobeNewswire

3 hours ago

Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure

Indeterminate GlobeNewswire

3 hours ago

neurocare and Wave Neuroscience partner to expand patient access to FDA-Cleared MeRT® therapy for PTSD on the Apollo TMS Therapy System

Indeterminate GlobeNewswire

3 hours ago

Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

Indeterminate GlobeNewswire

3 hours ago

Cerenome to Hold CNSide® Business Update Call on September 30, 2026

Indeterminate GlobeNewswire

4 hours ago

Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in The Bahamas to Provide OCU400 to Patients for Treatment of Retinitis Pigmentosa

Indeterminate GlobeNewswire

4 hours ago

Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion

Indeterminate GlobeNewswire

4 hours ago

C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting

Indeterminate GlobeNewswire

4 hours ago

Sernova Biotherapeutics to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference

Indeterminate GlobeNewswire

4 hours ago

Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN

Indeterminate GlobeNewswire

4 hours ago

Omotesando Helene Clinic and Maison Privé Clinic Sign Cooperation Agreement on International Medical Exchange and Patient Support

Indeterminate GlobeNewswire

8 hours ago

European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

Indeterminate GlobeNewswire

9 hours ago

Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer

Indeterminate GlobeNewswire

10 hours ago

Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior

Indeterminate GlobeNewswire